Synthesis of Reverse-Flex Cytosine Nucleoside Analogues As Potential Antiviral Therapeutics

dc.contributor.authorSmart, Viviana
dc.contributor.authorWaters, Charlie
dc.contributor.authorSeley-Radtke, Katherine
dc.date.accessioned2024-03-06T18:52:12Z
dc.date.available2024-03-06T18:52:12Z
dc.date.issued2022-04-18
dc.descriptionUMBC 26th Undergraduate Research and Creative Achievement Day (URCAD), April 18-24, 2022
dc.description.abstractThe aim for the current project is to synthesize reverse flex-Cytosine nucleosides and their prodrugs, as well as to apply modifications at the C5’ position of the pyrimidine base in order to explore new potential antiviral activity against coronaviruses and other viruses being targeted by our research group.
dc.description.sponsorshipSeley-Radtke Lab, HHMI, Meyerhoff, NIH/NIGMS T32 GM066706 (KSR and CW)
dc.description.urihttps://umbc.voicethread.com/myvoice/thread/19802663/
dc.format.extent10 pages
dc.genreconference papers and proceedings
dc.genrepresentations (communicative events)
dc.identifierdoi:10.13016/m2oume-reaj
dc.identifier.urihttp://hdl.handle.net/11603/31831
dc.language.isoen
dc.relation.isAvailableAtThe University of Maryland, Baltimore County (UMBC)
dc.relation.ispartofUMBC Faculty Collection
dc.relation.ispartofUMBC Student Collection
dc.relation.ispartofUMBC Chemistry & Biochemistry Department
dc.rightsThis item is likely protected under Title 17 of the U.S. Copyright Law. Unless on a Creative Commons license, for uses protected by Copyright Law, contact the copyright holder or the author.
dc.subjectNucleoside analogues
dc.subjectReverse Fleximers
dc.subjectAntiviral Therapeutics
dc.titleSynthesis of Reverse-Flex Cytosine Nucleoside Analogues As Potential Antiviral Therapeutics
dc.title.alternativeSynthesis of Reverse Fleximer-Cytosine Nucleoside Analogues as Potential Antiviral Therapeutics
dc.typeText
dcterms.creatorhttps://orcid.org/0000-0002-0154-3459

Files